Changes in fluoroquinolone-resistant Streptococcus pneumoniae after 7-valent conjugate vaccination, Spain.
about
In vitro antibacterial activities of JNJ-Q2, a new broad-spectrum fluoroquinolonePrevalence and clonal characterization of Streptococcus pyogenes clinical isolates with reduced fluoroquinolone susceptibility in Spain.Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996-1997 to 2006-2007).The relBE2Spn toxin-antitoxin system of Streptococcus pneumoniae: role in antibiotic tolerance and functional conservation in clinical isolates.Spread of Streptococcus pneumoniae serotype 8-ST63 multidrug-resistant recombinant Clone, SpainNew alkaloid antibiotics that target the DNA topoisomerase I of Streptococcus pneumoniaeSerotypes of Streptococcus pneumoniae isolates from children with invasive pneumococcal disease in Turkey: baseline evaluation of the introduction of the pneumococcal conjugate vaccine nationwide.Susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada.Induction of prophages by fluoroquinolones in Streptococcus pneumoniae: implications for emergence of resistance in genetically-related clones.Emergence of Amoxicillin-Resistant Variants of Spain9V-ST156 Pneumococci Expressing Serotype 11A Correlates with Their Ability to Evade the Host Immune ResponseGlobal fluoroquinolone resistance epidemiology and implictions for clinical use.Pneumococci can persistently colonize adult patients with chronic respiratory diseaseThe fluoroquinolone levofloxacin triggers the transcriptional activation of iron transport genes that contribute to cell death in Streptococcus pneumoniae.Elderly patients with community-acquired pneumonia: optimal treatment strategies.Resistance surveillance studies: a multifaceted problem--the fluoroquinolone example.Levofloxacin for the treatment of respiratory tract infections.Risk factors and clinical significance of invasive infections caused by levofloxacin-resistant Streptococcus pneumoniae.Fluoroquinolone-resistant pneumococci: dynamics of serotypes and clones in Spain in 2012 compared with those from 2002 and 2006.Fluoroquinolone resistance in Streptococcus dysgalactiae subsp. equisimilis and evidence for a shared global gene pool with Streptococcus pyogenes.Emergence of ciprofloxacin-nonsusceptible Streptococcus pyogenes isolates from healthy children and pediatric patients in Portugal.Implementation of a Meningitis Care Bundle in the Emergency Room Reduces Mortality Associated With Acute Bacterial Meningitis.Clonal spread of levofloxacin-resistant streptococcus pneumoniae invasive isolates in Madrid, Spain, 2007 to 2009.Characterization of recombinant fluoroquinolone-resistant pneumococcus-like isolates.Nonoptimal DNA topoisomerases allow maintenance of supercoiling levels and improve fitness of Streptococcus pneumoniae.Comparative study of the mutant prevention concentrations of moxifloxacin, levofloxacin, and gemifloxacin against pneumococci.Upregulation of the PatAB Transporter Confers Fluoroquinolone Resistance to Streptococcus pseudopneumoniae.Insights into the evolutionary trajectories of fluoroquinolone resistance in Streptococcus pneumoniae.
P2860
Q24629223-5B5DC524-BA96-4CFC-8427-D7EFF13A6947Q33558985-1904B380-9946-47FC-81B9-A8944BA2B476Q33571285-946F89CD-22F3-40BF-8A91-526BD43A6E01Q33619338-86EF8CB7-D52C-4C09-8253-28708D57C5BAQ34426636-5B150B4E-F5D2-4EFF-9DC1-F5BC010640A3Q34675643-8BF7FAA1-84B7-4429-BA33-23C154404E0CQ35066491-F6B4E1C3-C8AD-4848-BB71-094D4BFD3AA8Q35139545-C2D33BD8-052A-41DB-BBCE-729F4CAB6139Q35144206-19BB2739-DEEB-437B-B1D9-6390D318756FQ35773895-37230293-D149-462C-AE95-8D8CFB5FEA02Q36337074-7C481A09-DA25-4FFE-8AEE-59E8DC5E3E23Q36413948-44797BFB-04E4-4D19-A089-76CD5863CCE1Q37544432-3FE907A7-709E-4A58-A5D0-F4B3E1C13221Q37896600-4C706AC8-711D-4E2E-BB44-3D7E4F42CAC1Q37998398-4F216B7D-CC48-45AB-B076-C8C194102628Q38010784-602E6BBD-395F-4191-8858-D160C90FD32FQ38109582-B7A5480F-A65F-49D8-AF55-220800B82129Q39682438-B3E784EF-1F3C-428B-A038-937C46077F4EQ40334880-22742870-2347-430B-8C7B-79E7DCBC414BQ40750740-F8E957D7-8DF4-4CC8-AC5F-7CE9C9EF3B13Q41143802-EF80E19D-FB34-4428-8963-CFE8A2F63AE0Q42033336-AB6CB6D9-62D9-43F6-A41B-29823236E114Q42088108-6F79D638-17ED-4E71-9A46-E77C2B826E74Q42111122-90FA842F-F19B-4818-A871-AB00CEB4C2FBQ42127654-E89B7F3B-FC6B-4BDB-A389-F199F6C14C00Q47138989-FF421531-027A-42A5-8E08-1C67FFD2AF48Q53840555-14E05D8A-A002-49DB-93EC-36BA8EAD4AB9
P2860
Changes in fluoroquinolone-resistant Streptococcus pneumoniae after 7-valent conjugate vaccination, Spain.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Changes in fluoroquinolone-res ...... conjugate vaccination, Spain.
@en
Changes in fluoroquinolone-res ...... conjugate vaccination, Spain.
@nl
type
label
Changes in fluoroquinolone-res ...... conjugate vaccination, Spain.
@en
Changes in fluoroquinolone-res ...... conjugate vaccination, Spain.
@nl
prefLabel
Changes in fluoroquinolone-res ...... conjugate vaccination, Spain.
@en
Changes in fluoroquinolone-res ...... conjugate vaccination, Spain.
@nl
P2093
P2860
P356
P1476
Changes in fluoroquinolone-res ...... t conjugate vaccination, Spain
@en
P2093
Asunción Fenoll
Emilio Pérez-Trallero
Jose M Marimón
Josefina Liñares
Luz Balsalobre
P2860
P304
P356
10.3201/EID1506.080684
P577
2009-06-01T00:00:00Z